These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7685990)

  • 21. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
    Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor and antiproliferative effects of an aqueous extract from the marine diatom Haslea ostrearia (Simonsen) against solid tumors: lung carcinoma (NSCLC-N6), kidney carcinoma (E39) and melanoma (M96) cell lines.
    Carbonnelle D; Pondaven P; Morancais M; Masse G; Bosch S; Jacquot C; Briand G; Robert J; Roussakis C
    Anticancer Res; 1999; 19(1A):621-4. PubMed ID: 10226609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
    Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro histoculture of human tumors with fluorescent dye end-points measured by confocal microscopy: high correlation of in vitro and in vivo chemosensitivity.
    Guo HY; Colangelo D; Li L; Connors KM; Kubota T; Hoffman RM
    Anticancer Res; 1992; 12(4):1055-61. PubMed ID: 1323946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
    Hermann TW; Yen WC; Tooker P; Fan B; Roegner K; Negro-Vilar A; Lamph WW; Bissonnette RP
    Lung Cancer; 2005 Oct; 50(1):9-18. PubMed ID: 15993980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) against A549 non-small cell lung cancer cell line is related to its anti-invasive activity.
    Shibata J; Murakami K; Wierzba K; Aoyagi Y; Hashimoto A; Sano M; Toko T; Yamada Y
    Anticancer Res; 2000; 20(5A):3169-76. PubMed ID: 11062739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro chemosensitivity of human lung cancer cell lines.
    Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
    Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemosensitivity test for lung cancer].
    Nishio K; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):225-31. PubMed ID: 2355692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines.
    Liu C; Tsao MS
    Am J Pathol; 1993 Feb; 142(2):413-23. PubMed ID: 8382008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemosensitivity test for unresectable non-small cell lung cancer].
    Kawamura M; Inoue Y; Oyama T; Kobayashi K
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):229-32. PubMed ID: 11904985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A selective retinoid X receptor agonist bexarotene (Targretin) prevents and overcomes acquired paclitaxel (Taxol) resistance in human non-small cell lung cancer.
    Yen WC; Corpuz MR; Prudente RY; Cooke TA; Bissonnette RP; Negro-Vilar A; Lamph WW
    Clin Cancer Res; 2004 Dec; 10(24):8656-64. PubMed ID: 15623650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
    Harper E; Dang W; Lapidus RG; Garver RI
    Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers.
    Mijatovic T; Roland I; Van Quaquebeke E; Nilsson B; Mathieu A; Van Vynckt F; Darro F; Blanco G; Facchini V; Kiss R
    J Pathol; 2007 Jun; 212(2):170-9. PubMed ID: 17471453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of anti-tumour effect of thermochemotherapy with in vitro thermochemosensitivity testing for non-small cell lung cancer.
    Abiko T; Kawamura M; Izumi Y; Oyama T; Saito Y; Kobayashi K
    Int J Hyperthermia; 2007 May; 23(3):267-75. PubMed ID: 17523019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is class III beta-tubulin a true predictive marker of sensitivity to vinorelbine in non-small cell lung cancer? Chemosensitivity data evidence.
    Hirai Y; Yoshimasu T; Oura S; Ota F; Naito K; Nishiguchi H; Hashimoto S; Okamura Y
    Anticancer Res; 2011 Mar; 31(3):999-1005. PubMed ID: 21498728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammineglycolatoplatinum (254-S) and cis-diamminedichloroplatinum.
    Koenuma M; Kasai H; Uchida N; Wada T; Hattori M; Oguma T; Totani T; Inaba M
    Anticancer Res; 1995; 15(2):417-21. PubMed ID: 7763015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice.
    Geiger T; Müller M; Monia BP; Fabbro D
    Clin Cancer Res; 1997 Jul; 3(7):1179-85. PubMed ID: 9815797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.